Supplementary Methods

Strains and Templates
Supplementary
Yeast strains used in this study are listed in Supplementary Table S1 . Genes for mutational analysis were cloned into vector pRS314 (TRP1) (10) including their endogenous promoter and terminator regions. RPA190 was subcloned from plasmid pNOY16 (3). RPA34, RPO26 and RPC19 were cloned via PCR from yeast genomic DNA (strain S288C, Invitrogen).
Plasmid pGP5 (RPA43 cloned into pRS314) (5) was used for analysis of the A43 subunit.
Chromosomal tagging of RPA135 with a C-terminal TEV-Protein A-tag was performed using plasmid pYM8 as previously described (11) . Standard yeast genetic techniques and media were used for plasmid transformation and shuffling (12) .
Protein identification
Samples of the purified Pol I preparations were precipitated by Methanol/Chloroform and loaded on a 4-12 % NuPAGE™ Bis-Tris gel (Invitrogen). After electrophoresis using NuPAGE™ MOPS SDS running buffer (Invitrogen), the gel was stained with SimplyBlue™ SafeStain (Invitrogen) and the bands of interest were excised. The proteins were digested in-gel with modified sequencing grade Trypsin (Roche). Prior to analysis, the resulting peptides were desalted using ZipTip™ C 18 pipette tips (Millipore). Peptide mass fingerprints and MS/MS analyses were performed on an Applied Biosystems 4700 Proteomics Analyzer™ MALDI-TOF/TOF mass spectrometer using CHCA matrix and evaluated by S-7 searching the NCBInr protein sequence database with the Mascot™ search engine implemented in the GPS Explorer™ software (Applied Biosystems).
Site-directed mutagenesis
A scheme of the mutagenesis strategy is given in Supplementary Figure S3 . PCR reactions were performed with primers carrying the desired mutations on plasmids containing the gene for the respective Pol I subunit. The length of the PCR product was chosen to span a unique restriction site, which in turn was used to cut another aliquot of the same plasmid. 45-75 ng of the PCR product were transformed together with 15 ng of the linearized plasmid into a BSY420 (1n) wildtype yeast strain. Transformants were selected for the TRP1 marker contained on the vector. As a consequence only cells carrying a plasmid repaired by homologous recombination could form colonies. After plasmid isolation, vectors containing the mutation were selected by restriction analysis screening for a new restriction site, which was also introduced in the PCR primer, but results in a silent mutation. All constructs were verified by sequencing. The finished vectors, carrying the mutant alleles of the RPA-genes, were shuffled into the corresponding yeast shuffle-strains to obtain the strains listed in Supplementary Table S1 .
SL-screen
The general strategy used in the SL-screen is depicted in Supplementary Figure S4 . PCR products from genomic DNA, prepared from yeast strains carrying the desired deletion (EUROSCARF collection of S. cerevisiae gene deletion strains), were used to knock-out the corresponding genes in the strains NOY222, D101-I2, T4-1c, JAY444 and DLY200 by homologous recombination. Transformants were screened on YPD+G418 plates for the KanMX4 marker originally used to create the knock-outs. Gene deletions were verified via PCR. The resulting strains were transformed with the various phosphorylation site mutants of the respective Pol I subunit and screened for synthetic lethality or growth defects on SDC-Arg+Can for variants of NOY222 or SDC-Trp+5'FOA for the other shuffle-strains, respectively. T4-1c transformants were screened for genetic interactions on SDC-Trp plates.
S-8
6AU phenotyping
Equally sized colonies of yeast strains carrying the phosphorylation site mutations or the corresponding wild type genes were resuspended in H 2 O and serial dilutions were spotted on SDC-Ura plates with increasing amounts of 6-Azauracil (6AU) and on YPD plates as control.
Phenotypes were monitored after incubation at either 30 °C or 37 °C for 2 days (plates without 6AU) or 4-6 days (plates with 6AU).
Alkaline phosphatase treatment
Samples of the purified Pol I were incubated with alkaline phosphatase (Roche) or heat- 
Immunoprecipitation of Protein A-tagged Pol I
Yeast strains containing the various Pol I phosphorylation site mutations and a C-terminal Protein A-TEV-tag on A135 were cultured in 500 ml YPD to OD 600 = 1. Cells were lysed with glass beads in buffer IP1 (400 mM (NH 4 ) 2 SO 4 , 10 mM MgCl 2 , 150 mM HEPES pH 7.6, 20 % glycerol, 5 mM β-mercaptoethanol, 1 mM PMSF, 2 mM benzamidine). The resulting extracts were cleared by centrifugation at 100,000 g for 35 min (Kontron TFT 55.38, with custom made adapters for use with Beckman 1.5 ml Microfuge™ tubes). 5 -10 mg total protein was incubated with 40 µl IgG Sepharose™ 6 FF (GE Healthcare) for 2 h at 4 °C on a turning wheel. Washing steps were performed in 1 ml Mobicol columns (MoBiTec) using S-9 buffers IP2 (1 M NaCl, 20 mM HEPES pH 7.6, 0.5 % NP40, 0.05 % Triton X-100) and IP3 (100 mM NaCl, 50 mM Tris pH 7.5, 1.5 mM MgCl 2 , 0.15 % NP40, 0.5 mM DTT). Pol I was eluted from the IgG-beads by cleavage of the tag with TEV protease for 2 h at 16 °C in buffer IP3 and analyzed by western blotting as described for the alkaline phosphatase treated Pol I samples.
